Yayınlar & Eserler

Yayın Ağı
Makaleler 46
Tümü (46)
SCI-E, SSCI, AHCI (24)
SCI-E, SSCI, AHCI, ESCI (28)
ESCI (4)
Scopus (37)
TRDizin (9)
Diğer Yayınlar (3)

1. Simultaneous Determination of Glibenclamide, Metoprolol Tartrate, and Phenol Red Using HPLC-PDA: Application in Rat Intestinal Permeability Studies and Its Greenness Assessment Using NEMI, Analytical Eco-Scale, GAPI, MoGAPI, AGREE, AGREEprep, RAPI, BAGI, and CACI

SOYSEVEN M., KAYNAK M. S., Kaval B., ÇELEBİER M., AKGEYİK E., Musayeva F., et al.
BIOMEDICAL CHROMATOGRAPHY , cilt.39, sa.7, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

2. Preparation and Characterization of Vitamin C Aquasomes

Bwalya F., BARRE L., ERDEM M., KAYNAK M. S.
Recent Advances in Drug Delivery and Formulation , cilt.19, 2025 (Hakemli Dergi)

3. Structural characterization of degradation products of phenol red used as zero permeability marker in in-situ rat intestinal permeability studies by LCMS-IT-TOF

ÖZCAN S., KAYNAK M. S.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES , cilt.1250, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

4. Development of Chitosan-Coated Liposomes for Oral Delivery of Nadolol: Preparation, Characterization, and in vitro Permeability Studies

İpekci E., Çağlar E. Ş., KAYNAK M. S., Gündoğdu E., Okur N. Ü.
Current Pharmaceutical Design , 2025 (SCI-Expanded, Scopus) identifier identifier identifier

5. Formulation Optimization, Physicochemical Characterization, and Biocompatibility Assessment of Curcumin‐Loaded Aquasomes

Bwalya F., ERDEM M., KAYNAK M. S.
NANO SELECT , 2025 (ESCI)

6. Investigation of the Permeability of Antiretroviral Drugs Lamivudine and Valganciclovir via Single-Pass Intestinal Perfusion (SPIP) Method

ŞANLI S., KAYNAK M. S., Sanli N., Balta E. E.
CURRENT PHARMACEUTICAL ANALYSIS , sa.7, ss.585-596, 2024 (SCI-Expanded, Scopus) identifier

7. Favipiravir pharmacokinetics in COVID-19 patients with moderate to severe kidney dysfunction: Lessons learned for future use

Surmelioglu N., DEMİRTÜRK E., Ayhan N. A., Yesilyurt A. O., Bayrakci S., KAYNAK M. S., et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS , cilt.62, sa.8, ss.345-352, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

8. Exploring the Correlation between Ibuprofen Solubility and Permeability in Intestinal Disease Conditions

Kaynak M. S., Soyseven M., Kaval B., Çelebier M., Akgeyik E., Şahin S., et al.
ACTA PHARMACEUTICA SCIENCIA , cilt.62, sa.3, ss.593-609, 2024 (Scopus) Sürdürülebilir Kalkınma

9. Adapting Fabric Phase Sorptive Extraction as an Innovative Multitool for Sample Transfer and Extraction in Pharmacokinetic Analysis Followed by LC-MS Determination of Levofloxacin in Plasma Samples

Ekin Dolaksiz Y., KAYNAK M. S., Kabir A., Furton K. G., ÇELEBİER M.
ACS OMEGA , cilt.9, sa.17, ss.18995-19002, 2024 (SCI-Expanded, Scopus) identifier identifier

10. Thermosensitive gel of pomegranate peel extract as alternative for the treatment of local infections

Şahin A., Gül Ü. D., Bayazit G., Kaynak M. S.
ACTA Pharmaceutica Sciencia , cilt.62, sa.3, ss.647-659, 2024 (Scopus)

11. Development and UV-VIS Spectrophotometric analysis of an ease-of-use pediatric oral solution of dexamethasone for personalized therapies

Enes D., Fidan B. B., KAPLAN O., DOĞAN A., Altinoz S., ÇELEBİER M., et al.
JOURNAL OF RESEARCH IN PHARMACY , cilt.28, sa.5, ss.1791-1799, 2024 (ESCI, Scopus, TRDizin) identifier identifier

12. Enhancing Oral Bioavailability of Domperidone Maleate: Formulation, In vitro Permeability Evaluation In-caco-2 Cell Monolayers and In situ Rat Intestinal Permeability Studies

Okur N. U., Caglar E. S., KAYNAK M. S., Diril M., ÖZCAN S., KARASULU H. Y.
CURRENT DRUG DELIVERY , cilt.21, sa.7, ss.1010-1023, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

13. Determination of quality of tablets containing irbesartan and hydrochlorothiazide via newly developed and validated simultaneous HPLC method

KAVAL B., ÖZCAN S., KAYNAK M. S., ÇELEBİER M.
ACTA PHARMACEUTICA SCIENCIA , 2023 (Scopus)

14. A Newly Developed and Fully Validated HPLC Method for Simultenous Determination of in-situ Single Pass Intestinal Permeability of Domperidone, Metoprolol Tartarate and Phenol Red

ÖZCAN S., Caglar E. S., KAYNAK M. S., Ustundag Okur N.
JOURNAL OF RESEARCH IN PHARMACY , cilt.27, sa.3, ss.967-979, 2023 (ESCI, Scopus, TRDizin) Creative Commons License identifier identifier identifier

15. Release kinetics of 3D printed oral solid dosage forms: An overview

KAVAL B., KAPKIN E., KAYNAK M. S.
European Journal of Life Sciences , cilt.1, sa.2, ss.37-55, 2022 (Hakemli Dergi)

16. Ultrafiltration-based sample preparation and HPLC-UV determination of diclofenac in human plasma samples

NENNİ M., DOĞAN A., ÇELEBİER M., Soyseven M., KAYNAK M. S., Aboul-Enein H. Y., et al.
TURKISH JOURNAL OF CHEMISTRY , cilt.46, sa.3, ss.777-785, 2022 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier identifier

17. A review on collagen as a food supplement

Musayeva F., Özcan S., Kaynak M. S.
Journal of Pharmaceutical Technology , cilt.3, sa.1, ss.7-29, 2022 (TRDizin)

18. Determination of the Physicochemical Properties of Piroxicam

ÇELEBİER M., NENNİ M., KAPLAN O., Akgeyik E., KAYNAK M. S., ŞAHİN S.
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.17, sa.5, ss.535-541, 2020 (ESCI, Scopus, TRDizin) Creative Commons License identifier identifier identifier

19. Assessment of pharmaceutical quality and release kinetics of metoprolol tartrate extended release tablets available in Turkish drug market

GENCER A., AKGEYİK E., KAYNAK M. S., ÇELEBİER M., BERKMAN M. S., ŞAHİN S.
Anadolu Üniversitesi Bilim ve Teknoloji Dergisi :C-Yaşam Bilimleri ve Biyoteknoloji , cilt.9, sa.2, ss.179-189, 2020 (TRDizin) identifier

20. Development of a RP-HPLC method for simultaneous determination of reference markers used for in-situ rat intestinal permeability studies

SOYSEVEN M., KAYNAK M. S., ÇELEBİER M., Aboul-Enein H. Y., Arli G.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES , cilt.1147, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

21. Independent predictive factors for the persistence and tolerance of cow's milk allergy

TOPAL E., Celiksoy M. H., Arga M., KAYNAK M. S., DUMAN Y., Demirtas S., et al.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY , cilt.9, sa.1, ss.67-71, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

22. Demographics and clinical characteristic of patients diagnosed with hen’xxs egg allergy

TOPAL E., ARGA M., Celiksoy M. H., KAYNAK M. S., Duman Y., Demirtas S., et al.
Annals of Medical Research , cilt.26, sa.1, ss.1-4, 2019 (TRDizin) identifier

23. Comparison of intestinal permeability of nebivolol hydrochloride loaded solid lipid nanoparticles with commercial nebivolol tablet

GÖKÇE E. H., KAYNAK M. S., YURDASİPER A., ÜSTÜNDAĞ OKUR N., ŞAHİN S.
JOURNAL OF RESEARCH IN PHARMACY , cilt.22, sa.1, ss.248-256, 2018 (Scopus, TRDizin) identifier identifier

24. Development of HPLC Methods for Individual Determination of 20 Active Pharmaceutical Ingredients for Ussing-Chamber Studies

KAYNAK M. S., Akgeyik E., ATEŞ M., ÇELEBİER M., ŞAHİN S.
CURRENT PHARMACEUTICAL ANALYSIS , cilt.13, sa.2, ss.145-153, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

25. Preparation and evaluation of furosemide containing orally disintegrating tablets by direct compression

GÜLSÜN İNAL T., ÖZTÜRK N., KAYNAK M. S., VURAL İ., ŞAHİN S.
PHARMAZIE , cilt.72, sa.7, ss.389-394, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

26. Application of HPLC to Investigate the Physicochemical Properties and Intestinal Permeability of Ketoprofen

KAYNAK M. S., ÇELEBİER M., Akgeyik E., ŞAHİN S., Altinoz S.
CURRENT PHARMACEUTICAL ANALYSIS , cilt.13, sa.1, ss.72-79, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

27. Effect of permeability enhancers on paracellular permeability of acyclovir

Ates M., KAYNAK M. S., ŞAHİN S.
Journal of Pharmacy and Pharmacology , cilt.68, sa.6, ss.781-790, 2016 (SCI-Expanded, Scopus) identifier identifier

28. Evaluation of Pharmaceutical Quality of Conventional Dosage Forms Containing Paracetamol and Caffeine Available in the Turkish Drug Market

Akgeyik E., KAYNAK M. S., ÇELEBİER M., Altinoz S., ŞAHİN S.
DISSOLUTION TECHNOLOGIES , cilt.23, sa.2, ss.36-41, 2016 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

29. Comparison of dissolution profiles of commercially available Lamivudine tablets

ÖZTÜRK N., KAYNAK M. S., ŞAHİN S.
Dissolution Technologies , cilt.22, sa.4, ss.38-43, 2015 (SCI-Expanded, Scopus) Creative Commons License identifier

30. Simultaneous Determination of Acyclovir Metoprolol and Phenol Red by a RP HPLC Method for Intestinal Perfusion Studies

ATEŞ M., KAYNAK M. S., ŞAHİN S.
Hacettepe University Journal of the Faculty of Pharmacy , cilt.35, sa.2, ss.146-161, 2015 (Scopus) identifier

31. Determination of regional intestinal permeability of diclofenac and metoprolol using a newly-developed and validated high performance liquid chromatographic method

KAYNAK M. S., BÜYÜKTUNCEL S. E., Caglar H., ŞAHİN S.
Tropical Journal of Pharmaceutical Research , cilt.14, sa.1, ss.163-170, 2015 (SCI-Expanded, Scopus) Creative Commons License identifier

32. UV spectrophotometric method for determination of the dissolution profile of rivaroxaban

ÇELEBİER M., KAYNAK M. S., Altınöz S., ŞAHİN S.
Dissolution Technologies , cilt.21, sa.4, ss.56-59, 2014 (SCI-Expanded, Scopus) Creative Commons License identifier

33. Determination of in vitro Dissolution Profiles of Amlodipine Besylate and Olmesartan Medoxomil Using a New "HPLC Method"

KAYNAK M. S., ÇELEBİER M., ŞAHİN S., Altinoz S.
REVISTA DE CHIMIE , sa.1, ss.27-30, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

34. Development and validation of a RP HPLC method for determination of solubility of furosemide

KAYNAK M. S., ŞAHİN S.
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.10, sa.1, ss.25-34, 2013 (Scopus, TRDizin) identifier

35. İntestinal absorpsiyonu artırmak amacıyla kullanılan permeasyon artırıcı ajanlar

ATEŞ M., KAYNAK M. S., ŞAHİN S.
Hacettepe University Journal of the Faculty of Pharmacy , cilt.33, sa.1, ss.117-146, 2013 (Scopus) identifier

36. Development of a HPLC Method for the Determination of Cyclosporine A From Chitosan Nanoparticles

BÜYÜKTUNCEL S. E., YÜCEL Ç., KAYNAK M. S., AKTAŞ Y.
LATIN AMERICAN JOURNAL OF PHARMACY , cilt.31, sa.8, ss.1083-1088, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

37. Determination of Amlodipine and Furosemide with newly developed and validated RP HPLC method in commercially available tablet dosage forms

ŞİMŞEK F. Ö., KAYNAK M. S., ŞANLI N., ŞAHİN S.
Hacettepe University Journal of the Faculty of Pharmacy , cilt.32, sa.2, ss.145-158, 2012 (Scopus) identifier

38. Bioavailability file Amlodipin

KAYNAK M. S., BOGACZ A., MICHAL S., ŞAHİN S.
FABAD JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.36, sa.4, ss.207-222, 2011 (Scopus)

39. HPLC method development for the simultaneous analysis of amlodipine and valsartan in combined dosage forms and in vitro dissolution studies

ÇELEBİER M., KAYNAK M. S., Altinoz S., ŞAHİN S.
BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.46, sa.4, ss.761-768, 2010 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

40. HPLC METHOD DEVELOPMENT AND VALIDATION: SIMULTANEOUS DETERMINATION OF DICLOFENAC, METOPROLOL AND PHENOL RED IN BIOLOGICAL MATRIX FOR INTESTINAL PERFUSION STUDIES

Caglar H., KAYNAK M. S., ŞAHİN S., Buyuktuncel E.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , sa.1, ss.179-181, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

41. Hepatic disposition of trimethoprim and sulfamethoxazole

ŞAHİN S., Sayai- E., KAYNAK M. S., Hincal A. A.
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY , cilt.30, sa.2, ss.135-140, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

42. Validated HPLC method development The simultaneous analysis of amlodipine and valsartan in samples for liver perfusion studies

ÇELEBİER M., KAYNAK M. S., ALTINÖZ S., ŞAHİN S.
Hacettepe University Journal of the Faculty of Pharmacy , cilt.28, sa.1, ss.15-30, 2008 (Scopus) identifier

43. A New HPLC approach for determination of in vitro solubility of naproxen sodium

KAYNAK M. S., ŞAHİN S.
Hacettepe University Journal of the Faculty of Pharmacy , cilt.28, sa.1, ss.49-62, 2008 (Scopus) identifier

44. Formulation of controlled release glipizide pellets using pan coating method

KAYNAK M. S., KAŞ H. S., ÖNER L.
Hacettepe University Journal of the Faculty of Pharmacy , cilt.27, sa.2, ss.93-106, 2007 (Hakemli Dergi)

45. Bioavailability file Glipizide

KAYNAK M. S., ÖNER L.
FABAD JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.31, sa.3, ss.151-161, 2006 (Scopus)

46. Potential use of freeze-drying technique for estimation of tissue water content

Sahin S., Karabey Y., KAYNAK M. S., Hincal A. A.
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY , cilt.28, sa.4, ss.211-215, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 68

1. A novel RP-HPLC method to determine irbesartan and hydrochlorothiazide in fixed dose combinations: method development and validation

KAVAL B., ÖZCAN S., KAYNAK M. S.
13th International Symposium on Pharmaceutical Science, Ankara, Türkiye, 21 Haziran 2021, (Özet Bildiri)

2. Development and validation of RP-HPLC method for simultaneous determination of standard compounds used in-situ rat intestinal permeability studies

KAYNAK M. S., SOYSEVEN M., ARLİ G.
3rd International Eurasian Conference on Biological and Chemical Sciences (EurasianBioChem 2020), Ankara, Türkiye, 21 - 23 Mart 2020, (Özet Bildiri)

3. Development of a novel Reverse Phase HPLC method for the simultaneous analysis of metoprolol tartrate and phenol red in intestinal perfusion samples

KAYNAK M. S., SOYSEVEN M., ARLİ G.
ScİX 2019 presented by Federation of Analytical Chemistry and Spectroscopy Societies, 13 - 18 Ekim 2019, (Özet Bildiri)

4. Ghrelinin Yanık Yarası İyileşmesine Etkisi

Çiçek T., CERAN ÖZCAN C., OTLU H. G., KAYNAK M. S., TAŞLIDERE A., Yetiş M. İ., et al.
36. Ulusal Çocuk Cerrahisi ve 3. Uluslararası IPEG MEG ortak kongresi, İzmir, Türkiye, 24 - 27 Ekim 2018, ss.66, (Özet Bildiri)

5. Intestinal Perfusion Studies for Evaluation of Permeability of Drugs

KAYNAK M. S., ŞAHİN S.
Uluslararası Katılımlı 6. İlaç Kimyası: İlaç Etkin MaddesiTasarımı, Sentezi, Üretimi ve StandardizasyonuKongresi, 22 Mart 2018, (Tam Metin Bildiri)

6. Synthesis and Characterization of Silica Nanoparticles: Obtaining nanoparticles smaller than 100 nm

TONBUL H., AKBAŞ S., ULTAV G., ŞAHİN A., KAYNAK M. S., AKTAŞ Y., et al.
2nd International Gazi Symposium Series, 11 - 13 Ekim 2017, (Özet Bildiri)

7. Comparison of intestinal permeability of nebivolol hydrochloride in solid lipid nanoparticles and commercial tablet GPSS

GÖKÇE E. H., KAYNAK M. S., YURDASİPER A., ÜSTÜNDAĞ OKUR N., ŞAHİN S.
2nd Gazi Pharma Symposium (GPSS-2017), 11 - 13 Ekim 2017, (Özet Bildiri)

8. Comparison of HPLC and Spectrophotometric Methods on Determination of the pKa of Drugs

ÇELEBİER M., NENNİ M., KAPLAN O., AKGEYİK E., KAYNAK M. S., ALTINÖZ S., et al.
Symposium on Drug Research Development, 5 - 07 Ekim 2017, (Özet Bildiri)

9. Transferrine hedeflendirilmiş paklitaksel yüklü PLGA nanopartiküllerinin meme kanserindeki etkinliği

TONBUL H., ŞAHİN A., ÖZTÜRK N., VURAL İ., KAYNAK M. S., ÇAPAN Y.
1. Anadolu Üniversitesi Eczacılık Fakültesi Sempozyumu (ANES), Türkiye, 1 Haziran - 02 Ocak 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

10. Determination of pKa Value of Anticonvulsant Nafimidone Oxime O Propyl Ether

Akgeyik E., ÖZDEMİR Z., ATEŞ M., KAYNAK M. S., ÇELEBİER M., ALTINÖZ S., et al.
AAPS 2016, 13 - 17 Kasım 2016, (Özet Bildiri)

11. Development and Evaluation of Terbutaline Sulfate Containing Orally Disintegrating Tablets

İZAT N., AKDAĞ ÇAYLI Y., GÜLSÜN İNAL T., KAYNAK M. S., ÖNER L., ŞAHİN S.
AAPS 2016, 13 - 17 Kasım 2016, (Özet Bildiri)

12. Determination of Regional Intestinal Permeability of Valgancyclovir and Metoprolol Using a Newly Developed and Validated High Performance Liquid Chromatographic Method

ŞANLI S., ŞANLI N., KAYNAK M. S.
10th Aegean Analytical Chemsitry Days, 29 Eylül - 02 Ekim 2016, (Özet Bildiri)

13. Investigation of the stability of prednisolone powder for injection after reconstitution

ÇELEBİER M., KAYNAK M. S., NENNİ M., ALTINÖZ S., ŞAHİN S.
IPTS 2016, 18 - 21 Eylül 2016, (Tam Metin Bildiri)

14. Development and in vitro evaluation of transferrin targeted PLGA nanoparticles

TONBUL H., ŞAHİN A., KAYNAK M. S., ÇAPAN Y.
IPTS 2016, 18 - 21 Eylül 2016, (Tam Metin Bildiri)

15. Development of Metformin Hydrochloride and Glyburide Containing Orally Disintegrating Tablets

GÜLSÜN İNAL T., İZAT N., AKDAĞ ÇAYLI Y., KAYNAK M. S., ÖNER L., ŞAHİN S.
AAPS 2015, American Association of Pharmaceutical Scientists' Annual Meeting and Exposition, 25 - 29 Ekim 2015

16. Development of HPLC Methods for Individual Determination of 20 Active Pharmaceutical Ingredients for Ussing-Chamber Studies

KAYNAK M. S., AKGEYİK E., ATEŞ M., ÇELEBİER M., ŞAHİN S.
International Multidisciplinary Symposium on Drug Research & Development (DRD 2015), Eskişehir, Türkiye, 17 - 19 Ekim 2015, (Özet Bildiri)

17. Quality Control of Extended Release Metoprolol Tartrate Tablets Available in Turkish Drug Market

GENÇER A., AKGEYİK E., KAYNAK M. S., ÇELEBİER M., ŞAHİN S.
MAGUM-DRD 2015, International Symposium on Drug Research and Development From Chemistry to Medicine, Eskişehir, Türkiye, 15 - 17 Ekim 2015

18. Assesment of Pharmaceutical Quality of Furosemide Tablets Available in Turkish Drug Market

YILDIZ B., AKGEYİK E., KAYNAK M. S., ÇELEBİER M., ŞAHİN S.
MAGUM-DRD 2015, International Symposium on Drug Research and Development From Chemistry to Medicine, Eskişehir, Türkiye, 15 - 17 Ekim 2015

19. Determination of Physicochemical Properties of Piroxicam

ÇELEBİER M., NENNİ M., KAPLAN O., AKGEYİK E., KAYNAK M. S., ALTINÖZ S., et al.
MAGUM-DRD 2015, International Symposium on Drug Research and Development From Chemistry to Medicine, Eskişehir, Türkiye, 15 - 17 Ekim 2015

20. HPLC Method Development for Analysis of Furosemide in Quality Control Laboratories

YILDIZ B., AKGEYİK E., KAYNAK M. S., ÇELEBİER M., ŞAHİN S.
Kromatografi 2015 UŞAK, Uşak, Türkiye, 8 - 10 Nisan 2015

21. Development of Orally Disintegrating Tablets Containing Olmesartan Medoxomil and Amlodipine Besylate

ÖZTÜRK N., GÜLSÜN İNAL T., KAYNAK M. S., VURAL İ., ŞAHİN S.
AAPS 2014, American Association of Pharmaceutical Scientists' Annual Meeting and Exposition, San Diego, Amerika Birleşik Devletleri, 2 - 06 Kasım 2014, (Özet Bildiri)

22. HPLC Method Development and Validation for Simultaneous Determination of Ketoprofen Metoprolol and Phenol Red

AKGEYİK E., ATEŞ M., KAYNAK M. S., ÇELEBİER M., ŞAHİN S., ALTINÖZ S.
AAPS 2014, American Association of Pharmaceutical Scientists' Annual Meeting and Exposition, San Diego, 2 - 06 Kasım 2014

23. Investigation of Curcumin Effect on the Intestinal Breast Cancer Resistance Protein

GÜDER F., KAYNAK M. S., ŞAHİN S.
AAPS 2014, American Association of Pharmaceutical Scientists' Annual Meeting and Exposition, San Diego, Amerika Birleşik Devletleri, 2 - 06 Kasım 2014 Sürdürülebilir Kalkınma

24. Investigation of Physicochemical Properties of Ketoprofen by HPLC

ÇELEBİER M., AKGEYİK E., ATEŞ M., KAYNAK M. S., ALTINÖZ S., ŞAHİN S.
AAPS 2014, American Association of Pharmaceutical Scientists' Annual Meeting and Exposition, San Diego, Amerika Birleşik Devletleri, 2 - 06 Kasım 2014

25. Potential Effect of Capsaicin on Intestinal Breast Cancer Resistance Protein

ŞENER E., KAYNAK M. S., ŞAHİN S.
AAPS 2014, American Association of Pharmaceutical Scientists' Annual Meeting and Exposition, San Diego, Amerika Birleşik Devletleri, 2 - 06 Kasım 2014 Sürdürülebilir Kalkınma

26. Investigation of Permeability Enhancers on Paracellular Permeability

ATEŞ M., KAYNAK M. S., ŞAHİN S.
AAPS 2014, American Association of Pharmaceutical Scientists' Annual Meeting and Exposition, San Diego, Amerika Birleşik Devletleri, 2 - 06 Kasım 2014

27. Investigation of Dose Effect on the Segmental Intestinal Permeability of Amlodipine

KAYNAK M. S., BOGACZ A., STELMASINSKI M., ATEŞ M., ŞAHİN S.
AAPS 2014, American Association of Pharmaceutical Scientists' Annual Meeting and Exposition, San Diego, Amerika Birleşik Devletleri, 2 - 06 Kasım 2014

28. Preparation and Evaluation of Furosemide Containing Orally Disintegrating Tablets by Direct Compression

GÜLSÜN İNAL T., ÖZTÜRK N., KAYNAK M. S., ŞAHİN S., VURAL İ.
AAPS 2014, American Association of Pharmaceutical Scientists’xx Annual Meeting and Exposition, San Diego, Amerika Birleşik Devletleri, 2 - 06 Kasım 2014, (Özet Bildiri)

29. Investigation of pH Effect on the Intestinal Permeability of Ketoprofen by HPLC A Basic Approach to correlate the in vitro and in situ Results

KAYNAK M. S., ÇELEBİER M., AKGEYİK E., ATEŞ M., ŞAHİN S., ALTINÖZ S.
ISC 2014, 30th International Symposium on Chromatography (Communicating Separation Science for the Future), Salzburg, Avusturya, 14 - 18 Eylül 2014, (Özet Bildiri)

30. Simultaneous Determination of Acyclovir Metoprolol and Phenol Red in Biological Matrix for Intestinal Perfusion Studies

ATEŞ M., KAYNAK M. S., ŞAHİN S.
17th International Pharmaceutical Technology Symposium. (IPTS 2014), Antalya, Türkiye, 8 - 10 Eylül 2014, (Tam Metin Bildiri)

31. Quality Control of Conventional Paracetamol and Caffeine Combined Dosage Forms in Turkish Drug Market

AKGEYİK E., ÇELEBİER M., KAYNAK M. S., ALTINÖZ S., ŞAHİN S.
17th International Pharmaceutical Technology Symposium. (IPTS 2014), Antalya, Türkiye, 8 - 10 Eylül 2014, (Tam Metin Bildiri)

32. Lamivudin in İntestinal Permeabilitesini Ters Faz Sıvı Kromatografik Yöntem ile Tayini

ŞANLI S., KAYNAK M. S., ERTÜRK E., GÜLPEMBE H., ŞANLI N.
7. Ulusal Analitik Kimya Kongresi, Kahramanmaraş, Türkiye, 1 - 05 Eylül 2014, (Özet Bildiri)

33. Oseltamivir Fosfat ın İntestinal Permeabilitesini Ters Faz Sıvı Kromatografik Yöntem ile Tayini

ERTÜRK E., KAYNAK M. S., ŞANLI S., HALAY G., ŞANLI N.
7. Ulusal Analitik Kimya Kongresi, Kahramanmaraş, Türkiye, 1 - 05 Eylül 2014, (Özet Bildiri)

34. Development and validation of a RP HPLC method for determination of lamivudine from drug dissolution studies

ÖZTÜRK N., KAYNAK M. S., BÜYÜKTUNCEL S. E., ŞAHİN S.
MAGUM-DRD 2013, International Multidisciplinary Symposium on Drug Research and Development - New Drug Entities & Cancer Research, Nanotechnology & Scientific and Industrial Perspectives, Antalya, Türkiye, 28 - 30 Kasım 2013

35. Comparison of dissolution profiles of lamivudine tablets marketed in Turkey

ÖZTÜRK N., KAYNAK M. S., ŞAHİN S.
MAGUM-DRD 2013, International Multidisciplinary Symposium on Drug Research and Development - New Drug Entities Cancer Research, Nanotechnology Scientific and Industrial Perspectives, Antalya, Türkiye, 28 - 30 Kasım 2013, (Özet Bildiri)

36. Investigation of dissolution characteristics of amorphous furosemide prepared by ball milling technique

ÖZTÜRK N., KAYNAK M. S., ŞENER M., ERDEMOĞLU M., ŞAHİN S.
MAGUM-DRD 2013, International Multidisciplinary Symposium on Drug Research and Development - New Drug Entities & Cancer Research, Nanotechnology & Scientific and Industrial Perspectives, Antalya, Türkiye, 28 - 30 Kasım 2013

37. Investigation of Curcumin Effect on Intestinal P glycoprotein

GÜDER F., KAYNAK M. S., ŞAHİN S.
AAPS 2012, American Association of Pharmaceutical Scientists' Annual Meeting and Exposition, Şikago, Amerika Birleşik Devletleri, 14 - 17 Ekim 2012

38. Effect of Capsaicin on Intestinal P glycoprotein

ŞENER E., KAYNAK M. S., ŞAHİN S.
AAPS 2012, American Association of Pharmaceutical Scientists' Annual Meeting and Exposition, Şikago, Amerika Birleşik Devletleri, 14 - 17 Ekim 2012

39. HPLC Method Development for Determination and In Vitro Dissolution Studies for Rivaroxaban

ÇELEBİER M., KOÇAK E., SÜSLÜ İ., KAYNAK M. S., ALTINÖZ S.
9th Central European Symposium on Pharmaceutical Technology, Dubrovnik, Hırvatistan, 20 - 22 Eylül 2012, (Özet Bildiri)

40. Preparation and in vitro evaluation of cyclosporine A loaded liposome chitosan nanoparticle complexes

AKTAŞ Y., YÜCEL Ç., BÜYÜKTUNCEL S. E., KAYNAK M. S., GÜL M.
16th International Pharmaceutical Technology Symposium. (IPTS 2012), Antalya, Türkiye, 10 - 12 Eylül 2012, (Tam Metin Bildiri)

41. Kitosan nanopartiküllerinden Siklosporn A tayini için HPLC metodu geliştirilmesi

BÜYÜKTUNCEL S. E., YÜCEL Ç., KAYNAK M. S., AKTAŞ Y.
Kromatografi Kongresi, 2012, Gaziosmanpaşa Üniversitesi, Tokat, Türkiye, 6 - 09 Haziran 2012

42. Simultaneous Determination of Amlodipine Metoprolol and Phenol Red in Biological Matrix for Intestinal Perfusion Studies

BOGACZ A., STELMASINSKI M., BÜYÜKTUNCEL S. E., KAYNAK M. S., ŞAHİN S.
MAGUM-DRD 2011, International Symposium on Drug Research and Development From Chemistry to Medicine, Antalya, Türkiye, 27 Mayıs - 29 Kasım 2011

43. Development of RP HPLC Method for the Determination of Amlodipine in Commercially Available Tablet Dosage Forms

FEVZİYE Ş., DİRİCAN K. Z., KAYNAK M. S., ŞANLI N., ŞAHİN S.
MAGUM-DRD 2011, International Symposium on Drug Research and Development from Chemistry to Medicine, Antalya, Türkiye, 27 - 29 Mayıs 2011

44. Comparision of Dissolution Profiles of Two Commercially Available Furosemide Tablets

GENEŞ M., ÖZTÜRK N., KAYNAK M. S.
MAGUM-DRD 2011, International Symposium on Drug Research and Development From Chemistry to Medicine, Antalya, Türkiye, 27 - 29 Mayıs 2011

45. Determination of Permeability of Diclofenac Sodium in the In Situ Intestinal Perfusion Preparation

KAYNAK M. S., ÇAĞLAR H., BÜYÜKTUNCEL S. E., ŞAHİN S.
MAGUM-DRD 2011, International Symposium on Drug Research and Development From Chemistry to Medicine, Antalya, Türkiye, 27 - 29 Mayıs 2011

46. Development and Validation of a RP HPLC Method for Determination of Furosemide in Tablet Dosage Forms

ŞİMŞEK F., ERDOĞDU S., KAYNAK M. S., ŞANLI N., ŞAHİN S.
MAGUM-DRD 2011, International Symposium on Drug Research and Development From Chemistry to Medicine, Antalya, Türkiye, 27 - 29 Mayıs 2011

47. Determination of In Vitro Dissolution Profiles of Amlodipine Besylate and Olmesartan Medoxomil Using a Newly Developed HPLC Method

KAYNAK M. S., ÇELEBİER M., ŞAHİN S., ALTINÖZ S.
PSWC-AAPS 2010, Pharmaceutical Sciences World Congress- American Association of Pharmaceutical Scientists' Annual Meeting and Exposition, New Orleans, Amerika Birleşik Devletleri, 14 - 18 Kasım 2010

48. Hepatic Disposition of Naproxen Sodium in Cirrhotic Rat Liver

KAYNAK M. S., ŞAHİN S.
PSWC-AAPS 2010, Pharmaceutical Sciences World Congress-American Association of Pharmaceutical Scientists' Annual Meeting and Exposition, New Orleans, Amerika Birleşik Devletleri, 14 - 18 Kasım 2010

49. Determination of time to reach steady state in different intestinal segments using phenol red

ŞENER E., KAYNAK M. S., ŞAHİN S.
PSWC-AAPS 2010, Pharmaceutical Sciences World Congress-American Association of Pharmaceutical Scientists' Annual Meeting and Exposition, New Orleans, Amerika Birleşik Devletleri, 14 - 18 Kasım 2010

50. Investigation of Hepatic Disposition of Furosemide in the Dual Perfused Cirrhotic Rat Liver

KAYNAK M. S., ŞAHİN S.
AAPS 2009, American Association of Pharmaceutical Scientists' Annual Meeting and Exposition, Los-Angeles, Şili, 8 - 12 Kasım 2009

51. Estimation of Distributional Spaces in the Dual Perfused Cirrhotic Rat Liver

KAYNAK M. S., ŞAHİN S.
AAPS 2009, American Association of Pharmaceutical Scientists' Annual Meeting and Exposition, Los-Angeles, Şili, 8 - 12 Kasım 2009

52. Method Development and Validation Simultaneous Determination of Diclofenac Metoprolol and Phenol Red in Biological Matrix for Intestinal Perfusion Studies

ÇAĞLAR H., KAYNAK M. S., ŞAHİN S., BÜYÜKTUNCEL S. E.
3rd BBBBosphorus International Conference on Pharmaceutical Sciences, Antalya, Türkiye, 26 - 28 Ekim 2009

53. Development and Validation of a New HPLC Method with Fluorometric Detection for Analysis of Furosemide in Samples for Liver Perfusion Studies

KAYNAK M. S., ŞAHİN S.
69th International Congress of FIP, İstanbul, Türkiye, 3 - 08 Eylül 2009

54. HPLC Determination of Olmesatran Medoxomil and Amlodipine Besylate in Tablets

ÇELEBİER M., KAYNAK M. S., ALTINÖZ S., ŞAHİN S.
5th Conference on Separation and Related Techniques by Nordic Separation Sciences Society (NoSSS2009), Talin, Ermenistan, 26 - 29 Ağustos 2009

55. Determination of Naproxen Sodium in Samples for Liver Perfusion Studies via Newly Developed HPLC Method with Fluorometric Detection

KAYNAK M. S., ŞAHİN S.
ISOPS 2009, 9th International Symposium on Pharmaceutical Sciences, Ankara, Türkiye, 23 - 06 Haziran 2009

56. Determination of the In Vitro Dissolution profiles of Amlodipine and Valsartan Combined Tablet Dosage Forms by HPLC

KAYNAK M. S., ÇELEBİER M., ŞAHİN S., ALTINÖZ S.
MAGUM-DRD 2009, International Symposium on Drug Research and Development From Chemistry to Medicine, İstanbul, Türkiye, 4 - 07 Mayıs 2009

57. Determination of Tissue Water Contents of Cirrhotic Rats

KAYNAK M. S., YILDIZ I., ŞAHİN S.
AAPS 2008, American Association of Pharmaceutical Scientists' Annual Meeting and Exposition, Atlanta, Amerika Birleşik Devletleri, 16 - 20 Kasım 2008

58. Investigation of Intestinal Permeability of Naproxen Sodium and Furosemide in cirrhotic rats

KAYNAK M. S., YILDIZ I., ŞAHİN S.
AAPS 2008, American Association of Pharmaceutical Scientists' Annual Meeting and Exposition, Atlanta, Amerika Birleşik Devletleri, 16 - 20 Kasım 2008

59. Simultaneous Determination of Amlodipine Besylate and Valsartan in Tablets by HPLC

ÇELEBİER M., KAYNAK M. S., ALTINÖZ S., ŞAHİN S.
6th Aegean Analytical Chemistry Days, Denizli, Türkiye, 9 - 12 Ekim 2008

60. HPLC Method Development for the Simultaneous Analysis of Amlodipine Besylate and Valsartan in Samples for Liver Perfusion Studies

ÇELEBİER M., KAYNAK M. S., ALTINÖZ S., ŞAHİN S.
XX Congress of Chemist and Technologists of Macedonia with V Congress of Metallurgists of Macedonia, Ohrid, Makedonya, 17 Eylül - 20 Ağustos 2008

61. Determination of Specific Hepatic Arterial Space in Cirrhotic Rats

KAYNAK M. S., ŞAHİN S.
14th International Pharmaceutical Technology Symposium (IPTS 2008), Antalya, Türkiye, 6 - 10 Eylül 2008, (Tam Metin Bildiri)

62. Investigation of Solubility and Permeability Characteristics of Furosemide

KAYNAK M. S., ŞAHİN S., HINCAL A.
3rd World Congress of Board of Pharmaceutical Sciences of FIP (PSWC), Amsterdam, Hollanda, 22 - 25 Nisan 2007

63. Determination of solubility and intestinal permeability Naproxen Sodium

KAYNAK M. S., ŞAHİN S., HINCAL A.
Pre-Satellite Meeting for and by Ph.D. Students and Postdoctoral Fellows of the 3rd World Congress of Board of Pharmaceutical Sciences of FIP (PSWC), Amsterdam, Hollanda, 20 - 21 Nisan 2007

64. Hepatic Disposition of Trimethoprim and Sulfamethoxazole

ŞAHİN S., SAYAR E., KAYNAK M. S., HINCAL A.
13th International Pharmaceutical Technology Symposium IPTS 2006, 10 - 13 Eylül 2006, (Tam Metin Bildiri)

65. Potential Use of Freeze Drying Technique for Determining of Tissue Water

ŞAHİN S., KARABEY Y., KAYNAK M. S., ATİLLA H.
1st BBBB Conference on Pharmaceutical Sciences, Siofok, Macaristan, 26 - 28 Eylül 2005

66. Estimation of Distributional Volumes in The Perfused Rat Liver

KARABEY Y., KAYNAK M. S., ŞAHİN S., ÖNER L., HINCAL A.
8th European Congress of Pharmaceutical Science, EUFEPS 2004, Brüksel, Belçika, 17 - 20 Ekim 2004, cilt.23, ss.71

67. A Comparative Study on Controlled Release Hydrophilic Matrix Tablets Containing Glipizide

KAYNAK M. S., KAŞ S., ÖNER L.
11th International Pharmaceutical Technology Symposium (IPTS 2002), İstanbul, Türkiye, 9 - 11 Eylül 2002, (Tam Metin Bildiri)

68. Formulation of controlled release glipizide pellets using pan coating method

KAYNAK M. S., KAŞ H. S., ÖNER L.
10th International Pharmaceutical Technology Symposium. (IPTS 2000), İstanbul, Türkiye, 11 - 13 Eylül 2000, (Tam Metin Bildiri)
Kitaplar 12

1. METOPROLOL TARTRAT VE FENOL KIRMIZISININ EŞ ZAMANLI YPSK ANALİZİ: BAĞIRSAK PERFÜZYON ÇALIŞMALARINA YÖNELİK YÖNTEMLER

SOYSEVEN M., KAYNAK M. S.
Farmakolojide Güncel Çalışmalar, SÖĞÜT ÖZLEM, Editör, Livre de Lyon, Lyon, ss.39-50, 2024

2. Metoprolol Tartrat ve Fenol Kırmızısının Eş Zamanlı YPSK Analizi: Bağırsak Perfüzyon Çalışmalarına Yönelik Yöntemler

SOYSEVEN M., KAYNAK M. S.
Farmakolojide Güncel Çalışmalar, SÖĞÜT ÖZLEM, Editör, Livre de Lyon, Lyon, ss.39-50, 2024

3. Importance of Perfusion Medium in Single Pass Rat Intestinal Permeability (SPIP) Studies

ALSAWAIE A., KAYNAK M. S.
Current Research in Medicine and Health Sciences-2024, YALIN SERAP, ERASLAN MERİÇ, Editör, Livre de Lyon, Lyon, ss.167-186, 2024

4. DISSOLUTION METHODS IN NOVEL DRUG DELIVERY SYSTEMS

Barre L., AYAZ İ., KAYNAK M. S.
Recent Researches in Health Sciences-2024, DEVECİ HACİ AHMET, MOR NERİMAN, Editör, Livre de Lyon, Lyon, ss.247-265, 2024

5. AQUASOMES: A NOVEL CARRIER FOR IMPROVED DRUG SOLUBILITY AND PERMEABILITY

Bwalya F., Kaynak M. S.
Recent Advances in Medicine and Health Sciences: Concepts, Researches and Practice, Nazmi Duran,Feray Aydın, Editör, Livre de Lyon, Lyon, ss.107-118, 2023

6. NANOSTRUCTURED LIPID CARRIER AS A NOVEL INSIGHT FOR ORAL BIOAVAILABILITY ENHANCEMENT OF POORLY WATER SOLUBLE DRUGS

Barre L., Kaynak M. S.
Recent Advances in Medicine and Health Sciences: Concepts, Researches and Practice, Nazmi Duran,Feray Aydın, Editör, Livre de Lyon, Lyon, ss.275-290, 2023

7. Sodium lauryl sulfate as a surfactant used to enhance the solubility of poorly water- soluble drugs by micellar solubilization.

Alhusaini A., KAYNAK M. S.
Recent Advances in Natural and Engineering Sciences, Oduncuoğlu Murat, Kurt Halil İbrahim, Editör, Livre de Lyon, Lyon, ss.1-14, 2023

8. TOPİKAL İLAÇ FORMÜLASYONLARI VE UYGULAMALARI

Kaval B., Öztürk A. A., Kaynak M. S.
Güncel Tıp ve Sağlık Bilimleri Çalışmaları Kavramlar, Araştırmalar ve Uygulama, Sevda Eliş Yıldız, Ebru Karadağ Sarı, Editör, Livre de Lyon, Lyon, ss.1-28, 2023

9. Nanosponge-based drug delıvery for overcomıng solubılıty and permeabılıty challenges of poorly water-soluble drugs.

Irakoze N., KAYNAK M. S.
Medicine and Health Sciences Modern Analysis, Finding and Researches, Arslan Serkan, Azizoğlu Mustafa, Editör, Livre de Lyon, Lyon, ss.177-196, 2023

10. ECZANE TEKNİKERLERİ İÇİN TEMEL MATEMATİK

KAYNAK M. S., BERKMAN M. S.
TEY TÜRK EĞİTİM YAYINLARI, Niğde, 2020

11. TÜRK FARMAKOPESl-ll MONOGRAFLAR (Avrupa Farmakopesi Adaptasyonu) - 2016

ÖZKAN Y., SALTAN H. G., SARAÇ TARHAN S., ÖZKAN S. A., AYDIN A., SÜZEN H. S., et al.
T.C. Sağlık Bakanlığı Türkiya ilaç veTıbbl Cihaz. Kurumu, Ankara, 2016

12. Türk Farmakopesi II 2016

ÖZKAN Y., SALTAN H. G., SARAÇ TARHAN S., AYDIN A., ÖZKAN S. A., SÜZEN H. S., et al.
TC Sağlık Bakanlığı, 2016
Metrikler

Yayın

126

Yayın (WoS)

28

Yayın (Scopus)

37

Atıf (WoS)

128

H-İndeks (WoS)

7

Atıf (Scopus)

93

H-İndeks (Scopus)

6

Atıf (Scholar)

415

H-İndeks (Scholar)

12

Atıf (TrDizin)

1

H-İndeks (TrDizin)

1

Atıf (Diğer Toplam)

415

Proje

10

Tez Danışmanlığı

3

Açık Erişim

8
BM Sürdürülebilir Kalkınma Amaçları